Jeffrey D Rothstein
#104,328
Most Influential Person Now
Researcher
Jeffrey D Rothstein's AcademicInfluence.com Rankings
Jeffrey D Rothsteinphilosophy Degrees
Philosophy
#4182
World Rank
#6601
Historical Rank
Logic
#1698
World Rank
#2519
Historical Rank
Jeffrey D Rothsteinbiology Degrees
Biology
#5398
World Rank
#7869
Historical Rank
Neuroscience
#603
World Rank
#629
Historical Rank
Download Badge
Philosophy Biology
Jeffrey D Rothstein's Degrees
- PhD Neuroscience Johns Hopkins University
- Doctorate Medicine Johns Hopkins University
Why Is Jeffrey D Rothstein Influential?
(Suggest an Edit or Addition)Jeffrey D Rothstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD (2011) (3746)
- Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate (1996) (2495)
- Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia (2013) (1853)
- Localization of neuronal and glial glutamate transporters (1994) (1689)
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis (1995) (1464)
- From charcot to lou gehrig: deciphering selective motor neuron death in als (2001) (1353)
- β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression (2005) (1337)
- Oligodendroglia metabolically support axons and contribute to neurodegeneration (2012) (1295)
- Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. (1992) (1166)
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model (2003) (853)
- Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) (2002) (816)
- The C9orf72 repeat expansion disrupts nucleocytoplasmic transport (2015) (785)
- C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease (2014) (783)
- Mechanisms of Disease: astrocytes in neurodegenerative disease (2006) (778)
- Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS (2011) (763)
- Reactive astrocyte nomenclature, definitions, and future directions (2021) (698)
- Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis (1998) (697)
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention (2013) (693)
- Current hypotheses for the underlying biology of amyotrophic lateral sclerosis (2009) (680)
- NG2+ CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration (2010) (667)
- RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia (2013) (652)
- Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis (1990) (646)
- Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. (1993) (633)
- Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development (1997) (561)
- Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS (2010) (548)
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (2013) (522)
- Neuronal Regulation of Glutamate Transporter Subtype Expression in Astrocytes (1997) (506)
- Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis (2013) (465)
- The blood-brain barrier: an engineering perspective (2013) (436)
- Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues (2001) (432)
- Genome-wide Analyses Identify KIF5A as a Novel ALS Gene (2018) (414)
- Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis (2014) (404)
- Focal Transplantation-based Astrocyte Replacement is Neuroprotective in a Model of Motor Neuron Disease (2008) (391)
- Glutamate transporters: animal models to neurologic disease (2004) (362)
- Spectrin mutations cause spinocerebellar ataxia type 5 (2006) (353)
- 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes (1997) (343)
- Compromised Glutamate Transport in Human Glioma Cells: Reduction–Mislocalization of Sodium-Dependent Glutamate Transporters and Enhanced Activity of Cystine–Glutamate Exchange (1999) (341)
- Human endogenous retrovirus-K contributes to motor neuron disease (2015) (337)
- Glutamate transporters in neurologic disease. (2001) (324)
- Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. (1996) (321)
- Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons. (1998) (313)
- Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS (2002) (308)
- Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1* (2013) (307)
- Multiple Signaling Pathways Regulate Cell Surface Expression and Activity of the Excitatory Amino Acid Carrier 1 Subtype of Glu Transporter in C6 Glioma (1998) (305)
- Variations in Promoter Activity Reveal a Differential Expression and Physiology of Glutamate Transporters by Glia in the Developing and Mature CNS (2007) (299)
- Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. (1994) (298)
- Metabolic support of tumor-infiltrating regulatory T cells by lactic acid (2020) (290)
- Recovery from paralysis in adult rats using embryonic stem cells (2006) (283)
- Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading (2002) (283)
- Hypoxia—ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum (1997) (279)
- Trial of celecoxib in amyotrophic lateral sclerosis (2006) (271)
- The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. (2017) (267)
- A clinical trial of creatine in ALS (2004) (267)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (262)
- Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. (2004) (259)
- Human Embryonic Germ Cell Derivatives Facilitate Motor Recovery of Rats with Diffuse Motor Neuron Injury (2003) (257)
- Differential expression of three glutamate transporter subtypes in the rat retina (1996) (255)
- Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress–induced death of motor neurons in amyotrophic lateral sclerosis (2002) (248)
- Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins (2001) (246)
- A Neuronal Glutamate Transporter Contributes to Neurotransmitter GABA Synthesis and Epilepsy (2002) (245)
- Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex (1996) (243)
- Stress Granule Assembly Disrupts Nucleocytoplasmic Transport (2018) (242)
- C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins (2016) (242)
- Mutant Huntingtin Disrupts the Nuclear Pore Complex (2017) (238)
- Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4 (1997) (238)
- Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis (2011) (235)
- Modulation of the neuronal glutamate transporter EAAC1 by the interacting protein GTRAP3-18 (2001) (234)
- Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data (2007) (233)
- Presynaptic Regulation of Astroglial Excitatory Neurotransmitter Transporter GLT1 (2009) (233)
- Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: Reversal by tianeptine (2004) (226)
- EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex. (1998) (225)
- Neuroprotective Strategies in a Model of Chronic Glutamate‐Mediated Motor Neuron Toxicity (1995) (222)
- Antisense Knockdown of the Glial Glutamate Transporter GLT-1, But Not the Neuronal Glutamate Transporter EAAC1, Exacerbates Transient Focal Cerebral Ischemia-Induced Neuronal Damage in Rat Brain (2001) (221)
- Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-κB (2000) (218)
- Glutamatergic Enteric Neurons (1997) (214)
- Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors (2004) (214)
- Traumatic Brain Injury Down‐Regulates Glial Glutamate Transporter (GLT‐1 and GLAST) Proteins in Rat Brain (1998) (213)
- Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. (2003) (207)
- Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice (2011) (202)
- Oligodendroglia: metabolic supporters of axons. (2013) (202)
- A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis (2003) (199)
- Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis (2017) (196)
- Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS (2008) (196)
- Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. (1995) (195)
- Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies (2014) (190)
- Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease (2018) (188)
- Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure (1997) (184)
- Motor Neuron Disease Occurring in a Mutant Dynactin Mouse Model Is Characterized by Defects in Vesicular Trafficking (2008) (181)
- Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. (2013) (180)
- Oligodendroglia: metabolic supporters of neurons. (2017) (179)
- Rodent Models of Amyotrophic Lateral Sclerosis (2015) (174)
- Astrocyte Glutamate Transporters Regulate Metabotropic Glutamate Receptor-Mediated Excitation of Hippocampal Interneurons (2004) (169)
- The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease (2016) (168)
- Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. (1995) (161)
- Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial (2014) (156)
- Differential synaptic localization of the glutamate transporter EAAC1 and glutamate receptor subunit gluR2 in the rat hippocampus (2000) (156)
- Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesis (2013) (155)
- Distribution of Glutamate Transporter Subtypes During Human Brain Development (1997) (153)
- Alterations in Glutamate Transporter Protein Levels in Kindling‐Induced Epilepsy (1997) (146)
- Altered expression of the glutamate transporter EAAT2b in neurological disease (2004) (140)
- Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. (2020) (139)
- Regional Deafferentiation Down‐Regulates Subtypes of Glutamate Transporter Proteins (1995) (137)
- Neuronal Expression of the Glutamate Transporter GLT-1 in Hippocampal Microcultures (1998) (137)
- A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. (2009) (133)
- Signal-Crosstalk Between Rho/ROCK and c-Jun NH2-Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin II (2005) (131)
- Edaravone: A new drug approved for ALS (2017) (129)
- Regulation and dysregulation of glutamate transporters. (2006) (128)
- Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model. (2016) (128)
- Mechanisms for Reversible Regulation between G13 and Rho Exchange Factors* (2002) (127)
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research (2012) (126)
- Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis (1998) (123)
- Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT‐1/EAAT2 subtype (2006) (123)
- Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4‐2 and the serum and glucocorticoid‐inducible kinase isoforms SGK1/3 and protein kinase B (2003) (122)
- Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis–frontotemporal dementia phenotypes (2006) (122)
- Loss of β-III Spectrin Leads to Purkinje Cell Dysfunction Recapitulating the Behavior and Neuropathology of Spinocerebellar Ataxia Type 5 in Humans (2010) (122)
- Plasticity of astroglial networks in olfactory glomeruli (2011) (121)
- The Copper Chaperone CCS Is Abundant in Neurons and Astrocytes in Human and Rodent Brain (1999) (119)
- Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1). (1996) (118)
- Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis (2000) (118)
- Endogenous Benzodiazepine Receptor Ligands in Human and Animal Hepatic Encephalopathy (1990) (115)
- A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis (2010) (114)
- Excitotoxicity hypothesis (1996) (113)
- Neuronal activity regulates glutamate transporter dynamics in developing astrocytes (2012) (113)
- Viral-Induced Spinal Motor Neuron Death Is Non-Cell-Autonomous and Involves Glutamate Excitotoxicity (2004) (112)
- Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice (2006) (112)
- Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS (2007) (108)
- Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. (2000) (108)
- Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS (1991) (108)
- The Development of Excitatory Synapses in Cultured Spinal Neurons (1997) (105)
- Changes in expression of neuronal and glial glutamate transporters in rat hippocampus following kainate-induced seizure activity. (1999) (105)
- Localization of a toxic form of superoxide dismutase 1 protein to pathologically affected tissues in familial ALS (2012) (103)
- Climbing Fiber Activation of EAAT4 Transporters and Kainate Receptors in Cerebellar Purkinje Cells (2004) (103)
- Preclinical Testing of Neuroprotective Neurotrophic Factors in a Model of Chronic Motor Neuron Degeneration (1999) (102)
- Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis (2012) (102)
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention (2013) (102)
- Glutamate mediates platelet activation through the AMPA receptor (2008) (100)
- Evidence of neuronal excitatory amino acid carrier 1 expression in rat dorsal root ganglion neurons and their central terminals (2004) (99)
- Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis (2019) (98)
- Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (2013) (97)
- Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia (2000) (96)
- The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine (2001) (96)
- Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection (2006) (95)
- Non‐synaptic Localization of the Glutamate Transporter EAACI in Cultured Hippocampal Neurons (1997) (93)
- Excitatory amino acids in amyotrophic lateral sclerosis: An update (1991) (93)
- Glial cells in amyotrophic lateral sclerosis (2014) (92)
- Amyotrophic Lateral Sclerosis 2-Deficiency Leads to Neuronal Degeneration in Amyotrophic Lateral Sclerosis through Altered AMPA Receptor Trafficking (2006) (91)
- Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trials (2003) (90)
- Cytotoxicity by Matrix Metalloprotease-1 in Organotypic Spinal Cord and Dissociated Neuronal Cultures (2000) (88)
- Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression (2011) (88)
- Alteration of Striatal Glutamate Release After Glutamine Synthetase Inhibition (1984) (86)
- Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy (2019) (85)
- Safety, Pharmacokinetic, and Functional Effects of the Nogo-A Monoclonal Antibody in Amyotrophic Lateral Sclerosis: A Randomized, First-In-Human Clinical Trial (2014) (85)
- Propentofylline-induced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection (2008) (85)
- Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease (2019) (84)
- The Endoplasmic Reticulum Exit of Glutamate Transporter Is Regulated by the Inducible Mammalian Yip6b/GTRAP3-18 Protein* (2008) (81)
- Optimizing Nervous System-Specific Gene Targeting with Cre Driver Lines: Prevalence of Germline Recombination and Influencing Factors (2020) (80)
- Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy (1989) (80)
- Thrombin and Lysophosphatidic Acid Receptors Utilize Distinct rhoGEFs in Prostate Cancer Cells* (2004) (80)
- The Glutamate–Aspartate Transporter GLAST Mediates Glutamate Uptake at Inner Hair Cell Afferent Synapses in the Mammalian Cochlea (2006) (79)
- Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD (2006) (79)
- Motor neuron degeneration is attenuated in bax‐deficient neurons in vitro (1999) (78)
- Glutamate transporter expression and function in human glial progenitors (2004) (78)
- The genetic and molecular mechanisms of motor neuron disease (1998) (77)
- TGFβ Trophic Factors Differentially Modulate Motor Axon Outgrowth and Protection from Excitotoxicity (2000) (77)
- CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation (2019) (76)
- Nuclear Factor-κB Contributes to Neuron-Dependent Induction of Glutamate Transporter-1 Expression in Astrocytes (2011) (76)
- Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. (2001) (76)
- Epigenetic regulation of neuron‐dependent induction of astroglial synaptic protein GLT1 (2009) (76)
- Zones of Enhanced Glutamate Release from Climbing Fibers in the Mammalian Cerebellum (2010) (76)
- Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. (1999) (75)
- Calcium channel agonists and dystonia in the mouse (2000) (75)
- Activity and protein localization of multiple glutamate transporters in gestation day 14 vs. day 20 rat placenta. (1998) (74)
- Clinical trials of riluzole in patients with ALS (1996) (73)
- Localization of the high-affinity glutamate transporter EAAC1 in rat kidney. (1997) (73)
- C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import (2020) (70)
- Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis (2012) (69)
- Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS–FTD-linked UBQLN2 mutations (2016) (69)
- Reticulon RTN2B Regulates Trafficking and Function of Neuronal Glutamate Transporter EAAC1* (2008) (67)
- Glutamate receptor antagonists protect from virus‐induced neural degeneration (2004) (66)
- Tumor necrosis factor-α modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis (2009) (65)
- Therapeutic horizons for amyotrophic lateral sclerosis (1996) (65)
- β-III Spectrin Is Critical for Development of Purkinje Cell Dendritic Tree and Spine Morphogenesis (2011) (64)
- Fimbria‐Fornix Transections Selectively Down‐Regulate Subtypes of Glutamate Transporter and Glutamate Receptor Proteins in Septum and Hippocampus (1996) (63)
- Purification and Characterization of Naturally Occurring Benzodiazepine Receptor Ligands in Rat and Human Brain (1992) (62)
- Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush (2015) (62)
- Stereotyped spatial patterns of functional synaptic connectivity in the cerebellar cortex (2015) (61)
- G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD (2020) (61)
- A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation (2014) (61)
- Molecular cloning and expression of the rat EAAT4 glutamate transporter subtype. (1998) (61)
- Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS (2006) (60)
- Retinal colocalization and in vitro interaction of the glutamate receptor EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 (2004) (59)
- Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease (1999) (58)
- Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis (2020) (58)
- ENDOGENOUS BENZODIAZEPINES IN HEPATIC ENCEPHALOPATHY (1989) (55)
- Expression of the GLT-1 subtype of Na+-dependent glutamate transporter: pharmacological characterization and lack of regulation by protein kinase C. (1999) (54)
- Modulation of spinal nociceptive processing through the glutamate transporter GLT-1 (2002) (54)
- Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice (2003) (53)
- Calcium channel activation and self-biting in mice. (1999) (53)
- Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model (2019) (52)
- Glucocorticoid Regulation of GLT-1 Glutamate Transporter Isoform Expression in the Rat Hippocampus (2006) (50)
- Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor (1992) (50)
- Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitro (2005) (48)
- Arachidonic Acid Activates a Proton Current in the Rat Glutamate Transporter EAAT4* (1998) (47)
- A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells (2015) (46)
- Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin (2019) (45)
- Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. (2002) (45)
- Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis (2018) (44)
- MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration (2021) (44)
- Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS (2007) (44)
- Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. (1998) (44)
- Aggregate Formation in Cu,Zn Superoxide Dismutase-related Proteins* (2003) (43)
- Analysis of cerebellar Purkinje cells using EAAT4 glutamate transporter promoter reporter in mice generated via bacterial artificial chromosome-mediated transgenesis (2007) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Astrocyte Diversity: Current Insights and Future Directions (2020) (40)
- GLT-1 Promoter Activity in Astrocytes and Neurons of Mouse Hippocampus and Somatic Sensory Cortex (2009) (39)
- Biology of Tolerance and Dependence (1983) (39)
- Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. (1998) (39)
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS (2014) (39)
- Differential Abundance of Glutamate Transporter Subtypes in Amyotrophic Lateral Sclerosis (ALS)-Vulnerable versus ALS-Resistant Brain Stem Motor Cell Groups (1996) (39)
- Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunities (2020) (39)
- Tumor Necrosis Factor α Inhibits Glutamate Uptake by Primary Human Astrocytes (1996) (38)
- Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging (2020) (38)
- Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS (2021) (38)
- Glial and neuronal glutamate transport following glutamine synthetase inhibition. (1985) (37)
- GTRAP3-18 serves as a negative regulator of Rab1 in protein transport and neuronal differentiation (2008) (37)
- Reality and immortality—neural stem cells for therapies (2004) (36)
- The dysarthria—clumsy hand syndrome: A distinct clinical entity related to pontine infarction (1990) (36)
- Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines (2020) (35)
- Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study (2014) (35)
- Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 [correction]. (2004) (35)
- The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model (2019) (35)
- Potential Treatment of Amyotrophic Lateral Sclerosis with Gabapentin: A Hypothesis (1995) (34)
- Aquaporin 4 is increased in association with human immunodeficiency virus dementia: Implications for disease pathogenesis (2005) (34)
- Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury (2011) (33)
- Idiopathic recurring stupor (1994) (32)
- Regional and cellular expression of glial (GLT1) and neuronal (EAAC1) glutamate transporter proteins in ovine fetal brain (1998) (32)
- Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly. (2005) (31)
- TDP‐43 in amyotrophic lateral sclerosis: Pathophysiology or patho‐babel? (2007) (30)
- Excitotoxic destruction facilitates brain tumor growth (2001) (30)
- Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast‐derived iPS cells using zinc‐finger nuclease technology (2016) (29)
- The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons (2016) (28)
- Translocation of glutamate transporter subtype excitatory amino acid carrier 1 protein in kainic acid-induced rat epilepsy. (2003) (27)
- Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis (2021) (27)
- Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression (2007) (26)
- Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins (2007) (25)
- Neurologic manifestations of hepatic disease. (1989) (24)
- c9orf72 Disease-Related Foci Are Each Composed of One Mutant Expanded Repeat RNA. (2017) (24)
- Erratum: Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease (Neuron (2018) 99(5) (925–940.e7), (S0896627318306378) (10.1016/j.neuron.2018.07.039)) (2019) (23)
- Interaction of PDZRhoGEF with Microtubule-associated Protein 1 Light Chains (2006) (23)
- The transcription factor Pax6 contributes to the induction of GLT‐1 expression in astrocytes through an interaction with a distal enhancer element (2016) (23)
- Therapeutic developments in the treatment of amyotrophic lateral sclerosis (2002) (23)
- Glutamate transport in cultures from developing avian cerebellum: Presence of GLT‐1 immunoreactivity in Purkinje neurons (1998) (23)
- Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma. (2013) (23)
- Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers (2019) (22)
- TFEB/Mitf links impaired nuclear import to autophagolysosomal dysfunction in C9-ALS (2020) (22)
- Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS/FTD (2021) (21)
- Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice (2020) (21)
- Regulation of the Na+-coupled glutamate transporter EAAT3 by PIKfyve (2009) (21)
- C9ORF72-ALS/FTD: Transgenic Mice Make a Come-BAC (2016) (21)
- FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes (2019) (21)
- Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST (2016) (20)
- Human nasal olfactory epithelium as a dynamic marker for CNS therapy development (2011) (20)
- ALS Untangled No. 20: The Deanna Protocol (2013) (20)
- Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells (2018) (19)
- Release of endogenous benzodiazepine receptor ligands (endozepines) from cultured neurons (1992) (19)
- Models of Amyotrophic Lateral Sclerosis (2002) (19)
- Astroglia in Thick Tissue with Super Resolution and Cellular Reconstruction (2016) (18)
- Amyotrophic lateral sclerosis. An autoimmune disease? (1995) (18)
- Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models. (2014) (18)
- Derivation of Glial Restricted Precursors from E13 mice (2012) (17)
- A Helicase Unwinds Hexanucleotide Repeat RNA G-Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation. (2021) (17)
- Effects of the Convulsant Methionine Sulfoximine on Striatal Dopamine Metabolism (1982) (15)
- Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models (2021) (15)
- Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial (2022) (15)
- Regulation of Neurotransmitter Aspartate Metabolism by Glial Glutamine Synthetase (1986) (14)
- Benzodiazepine‐receptor ligands and hepatic encephalopathy: A causal relationship? (1994) (14)
- An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients (2020) (14)
- Paving new pathways (2002) (14)
- Quantitative analysis of EAAT4 promoter activity in neurons and astrocytes of mouse somatic sensory cortex (2010) (13)
- Astroglial transcriptome dysregulation in early disease of an ALS mutant SOD1 mouse model (2017) (12)
- Neurobiology: Bundling up excitement (2000) (12)
- Progranulin mutations and ALS or ALS-FTD phenotypes (2007) (12)
- Preclinical models: Needed in translation? A Pro/Con debate (2014) (11)
- Nuclear pore complexes — a doorway to neural injury in neurodegeneration (2022) (11)
- NAALADase inhibition protects motor neurons against chronic glutamate toxicity. (2003) (11)
- Excitotoxicity hypothesis. Discussion (1996) (10)
- ALSUntangled: Introducing The Table of Evidence (2015) (10)
- Plasma endogenous benzodiazepine-like activity in sleep disorders with excessive daytime sleepiness (1995) (10)
- Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform (2022) (10)
- RNA Is a Double-Edged Sword in ALS Pathogenesis (2021) (9)
- Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model (2018) (9)
- Preclinical studies: how much can we rely on? (2004) (9)
- Oligodendroglia metabolically support axons and maintain structural integrity (2013) (9)
- Use of antisense oligodeoxynucleotides to inhibit expression of glutamate transporter subtypes. (1998) (9)
- Specialized Neurotransmitter Transporters in Astrocytes (2009) (9)
- Increased synthesis of pro-inflammatory cytokines in C9ORF72 patients (2021) (8)
- Microglial response to the neurotoxicity of 6-hydroxydopamine in neonatal rat cerebellum (2001) (8)
- Glutamate Transporter Dysfunction and Neuronal Death (1999) (8)
- Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice. (2021) (8)
- ALSUntangled No. 16: Cannabis (2012) (8)
- Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export (2021) (7)
- A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS (2022) (7)
- ALSUntangled 15: Coconut Oil (2012) (6)
- Neurodegenerative disease: Two–for–one on potential therapies (2017) (6)
- Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD (2021) (6)
- ALSUntangled No. 26: Lunasin (2014) (6)
- ALS Untangled No. 17: “When ALS Is Lyme” (2012) (5)
- Analyzing progression of motor and speech impairment in ALS (2019) (5)
- Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy (1990) (5)
- UPF1 reduces C9orf72 HRE-induced neurotoxicity in the absence of nonsense-mediated decay dysfunction (2021) (5)
- Erratum: Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 (Investigative Opthalmology and Visual Science (2004) 45 (1442-1449)) (2004) (5)
- Activity and protein localization of multiple glutamate transporters in gestation day 14 vs. day 20 rat placenta. (1998) (5)
- ALSUntangled 38: L-serine (2017) (4)
- The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei (2021) (4)
- Results of a Phase 1, Double-Blind, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of ISIS 333611 Administered Intrathecally to Patients with Familial ALS Due to SOD1 Gene Mutations (S25.001) (2012) (4)
- Supplemental Information c 9 orf 72 Disease-Related Foci Are Each Composed of One Mutant Expanded Repeat RNA (4)
- Nuclear Pore Dysfunction in Neurodegeneration (2022) (4)
- Monocarboxylate transporter 1 in Schwann cells is critical for maintenance of sensory nerve myelination during aging (2019) (4)
- Subcellular and Subsynaptic Localization of Glutamate Transporters in the Monkey Basal Ganglia (2002) (4)
- Epidermal Growth Factor Receptor Agonists Increase Expression of Glutamate Transporter GLT-1 in Astrocytes through Pathways Dependent on Phosphatidylinositol 3-Kinase and Transcription Factor NFk B (2000) (3)
- Glutamate uptake by astroglia (2004) (3)
- Poly(ADP-ribose) promotes toxicity of C9ORF72 arginine-rich dipeptide repeat proteins (2022) (3)
- Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data (2022) (3)
- Hydrogen peroxide triggers an increase in cell surface expression of system xc − in cultured human glioma cells (2019) (3)
- MC-100093, a Novel β-Lactam Glutamate Transporter-1 Enhancer Devoid of Antimicrobial Properties, Attenuates Cocaine Relapse in Rats (2021) (2)
- 3D Printer Generated Tissue iMolds for Cleared Tissue Using Single- and Multi-Photon Microscopy for Deep Tissue Evaluation (2017) (2)
- G4C2 repeat RNA mediates the disassembly of the nuclear pore complex in C9orf72 ALS/FTD (2020) (2)
- C9orf72 arginine-rich dipeptide repeat proteins disrupt importin β-mediated nuclear import (2019) (2)
- Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review. (2022) (2)
- Amyotrophic lateral sclerosis : Disease targetily of newoportective therapies (2002) (1)
- Mutations of the glutamate transporter gene EAAT2 do not cause the abnormal EAAT2 transcripts in patients with amyotrophic lateral sclerosis (1997) (1)
- ALS--motor neuron disease: mechanism and development of new therapies. (2007) (1)
- KPT-350 reduces neurodegeneration and rescues aberrant nucleocytoplasmic transport in drosophila model of C9ORF72 ALS/FTD (2017) (1)
- Biochemical markers: Pro (2002) (1)
- Antiglutamate Therapies for Neurodegenerative Disease (1999) (1)
- Strand-specific antisense oligonucleotides for C9ORF72-ALS/FTD (S25.004) (2018) (1)
- GABAB receptors in mammalian function (1992) (1)
- Localization of the high-affinity glutamate transporter EAAC1 in rat kidney. (1997) (1)
- ALSUntangled No. 36: Accilion (2017) (1)
- ALSUntangled No. 34: GM604. (2016) (1)
- MC-100093, a novel β-lactam GLT-1 enhancer devoid of antimicrobial properties attenuates cocaine relapse in rats (2021) (1)
- 20 – Motor Neuron Disease: Amyotrophic Lateral Sclerosis (2007) (1)
- John W. “Jack” Griffin, MD (2011) (1)
- Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects (2023) (1)
- Endogenous benzodiazepines in a rat model of hepatic encephalopathy (1990) (1)
- The Role of NG2 Glial Cells in ALS Pathogenesis (2013) (1)
- Brainstem Motoneuron Cell Groups that die in Amyotrophic Lateral Sclerosis are Rich in the GLT-1 Glutamate Transporter (1996) (1)
- Identification of a unique molecular and functional microglia signature in health and disease. (2015) (1)
- REMOVED: Identification of a unique molecular and functional microglia signature in health and disease (2015) (1)
- Contents page + Editorial Board + Cover figure legend (2014) (0)
- Hepatic Encephalopathy and Portosystemic Encephalopathy (2003) (0)
- ALSUntangled No. 35: Hyperbaric Oxygen Therapy* (2016) (0)
- Monocarboxylate Transporter 1 (MCT1) is Critical for Regeneration in Peripheral Nerves (I6-1.001) (2014) (0)
- 653. Injection of AAV Directly into the Spinal Cord Increases Levels of Gene Expression (2005) (0)
- Newly Identified Layer Specific Cortical Astrocytes Regulate Synaptic and Dendritic Growth (2017) (0)
- Oligodendroglial MCT1 and Metabolic Support of Axons in Multiple Sclerosis (2015) (0)
- Glutamate transporters and ataxia: Zonal susceptibility of Purkinje cells to loss of EAAT4 and GLAST (2015) (0)
- The ultrastructure of differentiating iridophores and xanthophores in Aqulychnis dacnicolor (1977) (0)
- ALSUntangled No. 29: MitoQ (2015) (0)
- Immune Mediators as Biomarker Candidates in Familial Amyotrophic Lateral Sclerosis (P4.133) (2017) (0)
- Effects of development and hypoxia on glutamate transporters in rat brains (1998) (0)
- Author response: C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import (2020) (0)
- 3-50-02 An unusual case of idiopathic recurrent stupor with circadian rhythm — A new entity of the disease? (1997) (0)
- 650. AAV-IGF1 and Exercise for Synergistic Therapies in ALS (2005) (0)
- 652. Adeno-Associated Vector Delivery of Gutamate Transporters in an ALS Mouse Model (2005) (0)
- Astrocyte Diversity: Current Insights and Future Directions (2020) (0)
- tects motor neurons in culture from excitotoxic cell death 10 and prolongs survival in the mutant SOD 1 mouse model (2006) (0)
- Identification of a unique TGF-β–dependent molecular and functional signature in microglia (2013) (0)
- 517 Regulatory T cell functional identity is sustained by a glucose:lactate axis that is exploited in the tumor microenvironment (2020) (0)
- Chronic inhibition ofglutamate uptake produces amodelof slowneurotoxicity (1993) (0)
- arginine-rich dipeptide repeat proteins disrupt importin b-mediated nuclear import 1 2 (2021) (0)
- Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD (2021) (0)
- Astrocyte MCT1 expression does not contribute to the axonal degenerative phenotype observed with ubiquitous MCT1 depletion (2022) (0)
- NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency (2023) (0)
- 3D Printer Generated Tissue iMolds for Cleared Tissue Using Single- and Multi-Photon Microscopy for Deep Tissue Evaluation (2017) (0)
- Polyadenylated RNA and RNA-Binding Proteins Exhibit Unique Response to Hyperosmotic Stress (2021) (0)
- FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes (2019) (0)
- The ALS/FTD C9ORF72 hexanucleotide expansion disrupts nucleocytoplasmic transport (I8-2B) (2015) (0)
- Motor neuron growth factors. Discussion (1996) (0)
- 245. Delivery of IGF-1 in the Spinal Cord of a Mouse Model of ALS after Intraparenchymal Injection of an Adeno-Associated Vector (2006) (0)
- Nuclei Isolation and Super-Resolution Structured Illumination Microscopy for Examining Nucleoporin Alterations in Human Neurodegeneration. (2021) (0)
- Oligodendroglia/MCT1 are an unexpected contributor to CNS toxicity/neurodegeneration (2013) (0)
- Theme BW : Biomedical Work in Progress BW-01 C 9 ORF 72 patient specific iPSC-derived lines as ALS in vitro model (2017) (0)
- Anti-Excitotoxic and Antioxidant TGF-Beta Family Neurotrophic Factors: In Vitro Screening Models of Motor Neuron Degeneration (2001) (0)
- Mean plasma ozanezumab concentration-time profiles following single (A) or two (B) IV infusions of ozanezumab. (2014) (0)
- cloning led to the isolation of cDNAs for three glutamate transporter subtypes in nonhuman systems : GLAST (1998) (0)
- Erratum: Response to Stem cell differentiation (2004) (0)
- Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study (2014) (0)
- 46 – Amyotrophic Lateral Sclerosis: Idiopathic and Inherited (2007) (0)
- Response to Stem cell differentiation (2004) (0)
- Alteration of aspartate release after glutamine synthetase inhibition (1984) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Subject Index Vol. 83, 2006 (2006) (0)
- Chronic inhibition ofsuperoxide dismutase produces apoptotic deathofspinal neurons (1994) (0)
- Evaluating the utility of a picture description task for monitoring progression of ALS at home (2020) (0)
- 750 Transplantation of Human Neural Stem Cells in a New Primate Model of Motor Neuron Degeneration: An Experimental Study of Potential Cell Therapy for Amyotrophic Lateral Sclerosis (2001) (0)
- Amyotrophic lateral sclerosis (ALS) induced changes in basigin expression patterns (2011) (0)
- Hydrogen Peroxide Triggers an Increase in Cell Surface Expression of System x<sub>c</sub><sup>−</sup> in Cultured Human Glioma Cells (2020) (0)
- Modular glutamate transport compounds and methods. (2004) (0)
- ONTOGENY OF GLUTAMATE TRANSPORTERS IN THE SHEEP BRAIN. † 375 (1996) (0)
- Contents Vol. 83, 2006 (2006) (0)
- Reply (1991) (0)
- Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy (2019) (0)
- Effects of chronic and acute ethanol on striatal glutamine synthetase activity (1982) (0)
- Reply (1992) (0)
- The ESCRT-III protein VPS4, but not CHMP4B or CHMP2B, is pathologically increased in familial and sporadic ALS neuronal nuclei (2021) (0)
- Monocarboxylate Transporter 1 (Mct1) Is Critical For Schwann Cell Function In Regenerating Peripheral Nerves (2015) (0)
- Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin (2019) (0)
- Hexanucleotide repeat induced nuclear export and translation of circular intronic RNA in C9ORF72-ALS/FTD (2022) (0)
- Programme for the 112th Meeting of the British Neuropathological Society, Institute of Child Health, London, UK, 5–7 January 2011 (2011) (0)
- 1997 PEDIATRIC ACADEMIC SOCIETIES ’ ANNUAL MEETING SPONSORED BY THE AMERICAN PEDIATRIC Socnrr S 0 cIE ’ rY FOR PEDIATRIC RESEARCH AND AMULATORY PEDIATRIC ASSOCIATION (2004) (0)
- Critical Role For The Lactate Transporter, Monocarboxylate Transporter 1 (Mct1), In The Regeneration Of Peripheral Nerves (2011) (0)
- Enhanced susceptibility of motor neurons to excitotoxicity is dependent on Ca2+-permeable AMPA/kainate receptors and BAX expression (1997) (0)
- Comment by Dr. Jeffrey D. Rothstein (2006) (0)
- Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLAST. (2016) (0)
- The Evolving Landscape of Motor Neuron Disease Therapeutics (2022) (0)
- Tau Protein Disrupts Nucl eocytoplasmic Transport in Alzheimer ’ s Disease Graphical Abstract Highlights (2018) (0)
- Role of an Endogenous Retrovirus in ALS Pathophysiology and Effect of Anti-Retrovirals In Vitro (P5.203) (2016) (0)
- The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model (2019) (0)
- CRISPR-Cas 9 Screens Ide ntify the RNA Helicase DDX 3 X as a Repressor of C 9 ORF 72 ( GGGGCC ) n Repeat-Associated Non-AUG Translation Graphical (2019) (0)
- Stability and Redispersion of Platinum Nanoparticle Suspensions for Attachment to Dyes in Low-Cost Solar Cells (2016) (0)
- New Treatments in Amyotrophic Lateral Sclerosis (2011) (0)
- Biomarker Development for C9ORF72 Antisense Therapy Using iPS Neurons (S43.006) (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jeffrey D Rothstein?
Jeffrey D Rothstein is affiliated with the following schools:
